16
2022
-
11
Characteristic photoinitiators, medicines and intermediates, and fluorosilicone functional materials
Author:
Based on the team's rich operating experience and profound resource accumulation, the company has a very solid foundation and guarantee in new product research and development, technology industrialization transformation and product commercialization promotion. After more than five years of continuous development, the company has been successively rated as a national technology-based small and medium-sized enterprise, a high-tech enterprise in Tianjin, a fledgling eagle enterprise in Tianjin and a national high-tech enterprise. At present, the company has a school enterprise cooperation laboratory, two pilot test laboratories and two production cooperation factories, which are mainly responsible for the amplification and commercial production of technical projects, and has the ability to produce 1000 tons of special photoinitiators, fluoride functional materials and pharmaceutical intermediates annually.
At present, the company's main business is divided into three business divisions, namely, characteristic photoinitiators, pharmaceuticals and intermediates, and fluorosilicone functional materials. among
The Specialty Photoinitiator Business Department mainly deals in PAC photoinitiators for photoresists, oxime ester photoinitiators, cationic photoinitiators, visible light photoinitiators, water-based UV photoinitiators, macromolecular photoinitiators, and low odor photoinitiators for cigarette package inks.
In 2021, the company will cooperate with the First Construction Industry Construction Group to jointly establish Shandong Huirentong Electronic Materials Co., Ltd., focusing on the research, development and production of photoinitiators for photoresist and new electronic materials.
The main products of the Medicine and Intermediates Division include the intermediates of the anti breast cancer drug Fluvestran, the antihypertensive drug olmesartan ester, and the drug intermediates of Tralostam, Pergolide, and Pimobendan. Among them, our company is the largest manufacturer of pentafluoropentyl alcohol and pentafluoropentyl mercaptan, intermediates of Fluvix Group in China. With advanced technology and excellent quality, our company has entered the supply chain systems of the famous domestic pharmaceutical enterprises Zhengda Tianqing and New Era Pharmaceutical, and its sales volume will account for more than 60% of the domestic market in 2020.